Suchergebnisse - Ada Gjyrezi

  • Treffer 1 - 5 von 5
Treffer weiter einschränken
  1. 1
    HFT-T, a Targeting Nanoparticle, Enhances Specific Delivery of Paclitaxel to Folate Receptor-Positive Tumors

    HFT-T, a Targeting Nanoparticle, Enhances Specific Delivery of Paclitaxel to Folate Receptor-Positive Tumors von Xu Wang, Jun Li, Yiqing Wang, Kwang Jae Cho, Kim Gloria, Ada Gjyrezi, Lydia Koenig, Paraskevi Giannakakou, Hyung Ju C. Shin, Mourad Tighiouart, Shuming Nie, Zhuo Chen, Dong M. Shin

    Veröffentlicht 2009
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer

    Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer von Medha S. Darshan, Matthew S. Loftus, Maria Thadani‐Mulero, Benjamin Levy, Daniel Escuín, Xi Kathy Zhou, Ada Gjyrezi, Chantal Chanel‐Vos, Ruoqian Shen, Scott T. Tagawa, Neil H. Bander, David M. Nanus, Paraskevi Giannakakou

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Taxane resistance in prostate cancer is mediated by decreased drug-target engagement

    Taxane resistance in prostate cancer is mediated by decreased drug-target engagement von Ada Gjyrezi, Fang Xie, Olga Voznesensky, Prateek Khanna, Carla Calagua, Yang Bai, Justin W. Kung, Jim S. Wu, Eva Corey, Bruce Montgomery, Sandrine Macé, Diego A. Gianolio, Glenn J. Bubley, Steven P. Balk, Paraskevi Giannakakou, Rupal S. Bhatt

    Veröffentlicht 2020
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY

    Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY von Scott T. Tagawa, Emmanuel S. Antonarakis, Ada Gjyrezi, Giuseppe Galletti, Seaho Kim, Daniel Worroll, John A. Stewart, Atef Zaher, Ted P. Szatrowski, Karla V. Ballman, Katsuhiro Kita, Shinsuke Tasaki, Yang Bai, Luigi Portella, Brian J. Kirby, Fred Saad, Mario A. Eisenberger, David M. Nanus, Paraskevi Giannakakou

    Veröffentlicht 2018
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer

    Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastat... von Emmanuel S. Antonarakis, Scott T. Tagawa, Giuseppe Galletti, Daniel Worroll, Karla V. Ballman, Marie Vanhuyse, Guru Sonpavde, Scott North, Costantine Albany, Che‐Kai Tsao, John A. Stewart, Atef Zaher, Ted P. Szatrowski, Wei Zhou, Ada Gjyrezi, Shinsuke Tasaki, Luigi Portella, Yang Bai, Timothy B. Lannin, Shalu Suri, Conor Gruber, Erica D. Pratt, Brian J. Kirby, Mario A. Eisenberger, David M. Nanus, Fred Saad, Paraskevi Giannakakou

    Veröffentlicht 2017
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: